Processing your payment...
Please do not close your browser.

Growth Hormone Market Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions and By Key Players- Eli Lilly and Company, EMD Serono Inc., F. Hoffmann-La Roche AG, Ferring B.V., Genentech Inc

06 Jun, 2022 | 117 Pages
Shares
facebook sharing button
linkedin sharing button
twitter sharing button
sharethis sharing button

Acknowledging the kind of traction gained by this market, recently published a study report by industry data analytics asserts the Global Growth Hormone Market size is projected to accrue voluminously by 2027 registering a phenomenal CAGR of 7.6% during the review period (2022 to 2027).



Global Growth Hormone Market Overview



Human growth hormone (HGH), also known as somatotropin, is a peptide hormone responsible for growth stimulation, cell imitation, and cell regeneration in humans and is hence important for human development. Growth hormone (GH) deficiency in humans is caused when the hypophysis gland does not synthesize enough attention of hGH. This lack in humans is treated by administering recombinant human growth hormone by subcutaneous injection. Various genetic disorders, including Prader-Willi syndrome and Turner syndrome, may also cause growth hormone deficiency in humans, leading to delayed puberty and shorter-than-average height. In humans, the growth hormone deficiency is caused when the pituitary gland does not synthesize enough concentration of human growth hormones. This lack is treated by administering recombinant human growth hormones by subcutaneous injection. Various genetic disorders such as Prader-Willi syndrome and Turner syndrome may also cause development hormone deficiency, leading to delayed puberty and shorter-than-average height.



Human growth hormone helps promote renewal, reproduction, and growth. Bigger use of growth hormone and growth hormone awareness, which helps in the management of hormonal disparity disorders, enhances the market growth.



Who are the Prime Players in Growth Hormone Market?



The Global Growth Hormone Market includes identification and analysis of the various market participants competing in the global market. Prime competitors include Eli Lilly and Company, EMD Serono Inc., F. Hoffmann-La Roche AG, Ferring B.V., Genentech Inc., Ipsen, Merck KGaA, Novartis AG, Novo Nordisk, Pfizer Inc. and Sandoz, , TEVA PHARMACEUTICAL INDUSTRIES., Anhui Anke Biotechnology (Group) Co.,



Industry News and Updates:



Jan 20, 2022: Novo Nordisk launches anti-diabetes pill semaglutide in India



Novo Nordisk, the Danish drug maker on has announced the launch of oral semaglutide in India for treatment of type 2 diabetes.The oral semaglutide will cost Rs 315 per pill or around Rs 10000 for a full month treatment.




What are the major Applications, Types and Regions for Global Growth Hormone Market?



Market is segmented based on the type, applications, companies and regions.



By Type, it is segmented into




  • Short-Acting Growth Hormones

  • Long-Acting Growth Hormones



By Application, it is segmented into




  • Growth Hormone Deficiency

  • Idiopathic Short Stature

  • Turner Syndrome

  • Small For Gestational Age

  • Prader-Willi Syndrome

  • Others



Global Growth Hormone Market Regional Analysis



Asia Pacific is projected to register a significant CAGR over the forecast period. Key players focus on gaining a major market share in potential countries of the Asia Pacific such as Japan and China by gaining approval and the launch of novel products. For instance, in March 2017, Novo Nordisk A/S, a Denmark-based pharmaceutical company, initiated the phase III clinical trial of its HGH somapacitan, indicated for the treatment of adult growth hormone deficiency, in Japan.




  • North America


    • US

    • Canada



  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe



  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  •  Rest of the World

    • Middle East & Africa

    • Latin America





The Global Growth Hormone Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Growth Hormone Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.



What is our Global Growth Hormone Market scope?























































Report Attributes



Report Details



Forecast Period 2022 to 2028 CAGR



CAGR of 7.6% during the review period (2022 to 2027).



By Types




  • Short-Acting Growth Hormones

  • Long-Acting Growth Hormones



By Application




  • Growth Hormone Deficiency

  • Idiopathic Short Stature

  • Turner Syndrome

  • Small For Gestational Age

  • Prader-Willi Syndrome

  • Others



By Companies



Eli Lilly and Company, EMD Serono Inc., F. Hoffmann-La Roche AG, Ferring B.V., Genentech Inc



Regions Covered




  • North America

  • Europe

  • Asia-Pacific

  • Rest of the World



Countries Covered




  • US

  • Canada

  • Germany

  • France

  • UK

  • Italy

  • Spain

  • Rest of Europe

  • China

  • Japan

  • India

  • Australia

  • South Korea

  • Rest of Asia-Pacific

  • Middle East & Africa

  • Latin America



Base Year



      2022



Historical Year



       2017 to 2021



Forecast Year



      2022 to 2027



Number of Pages



    117



Customization Available



Yes, the report can be customized as per your needs




 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



Growth Drive –




  • GH deficiency was the largest application segment in 2019 owing to an increase in regulatory approvals and the launch of novel therapies

  • Rising awareness about GH deficiency, coupled with increasing hospital visits for its treatment, is expected to drive the hospital pharmacy distribution channel segment

  • North America dominated the human growth hormone market with the largest share in 2019. This is attributed to favorable reimbursement scenario, high awareness, and the presence of major players in the region



Frequently Asked Question



What is the study period of this market?



The Global Growth Hormone Market is studied from 2022-2027.



Who are the prime players in the Global Growth Hormone Market?



Eli Lilly and Company, EMD Serono Inc., F. Hoffmann-La Roche AG, Ferring B.V., Genentech Inc



Which region held the largest share in the Global Growth Hormone Market?



United States, Europe, China, Japan, Southeast Asia, India and Rest of World



What are the significant Types of   Global Growth Hormone Market?



Short-Acting Growth Hormones, Long-Acting Growth Hormones



What are the major Application of  Global Growth Hormone Market?



Growth Hormone Deficiency, Idiopathic Short Stature, Turner Syndrome, Small For Gestational Age, Prader-Willi Syndrome, Others



 



 


  1. INTRODUCTION

    1. MARKET DEFINATION

    2. MARKET DYNAMICS

    3. MARKET SEGMENTATION

    4. REPORT TIMLINES

    5. KEY STAKEHOLDERS



  2. RESEARCH METHODOLOGY

    1. DATA MINING

      1. SECONDARY RESEARCH

      2. PRIMARY RESEARCH

      3. SUBJECT MATTER EXPERT ADVICE



    2. QUALITY CHECK

    3. FINAL REVIEW

      1. DATA TRIANGULATION

      2. BOTTOM-UP APPROACH

      3. TOP-DOWN APPROACH



    4. RESEARCH FLOW



  3. EXECUTIVE SUMMARY

    1. INTRODUCTION

    2. GLOBAL GROWTH HORMONE MARKET BY TYPE

    3. GLOBAL GROWTH HORMONE MARKET BY APPLICTAION



  4. GLOBAL GROWTH HORMONE MARKET DYNAMICS

    1. DRIVERS

    2. INCREASING GROWTH HORMONE MARKET

    3. RESTRAINTS

      1. STRINGENT ENVIRONMENTAL REGUALTIONS

      2. HIGH COST ON MATERIALS



    4. OPPORTUNITIES

      1. GROWTH HORMONE MARKET GROWTH



    5. APPLICATION OF GLOBAL GROWTH HORMONE MARKET IMPACT OF COVID-19



  5. GLOBAL GROWTH HORMONE, BY TYPE



      1. INTRODUCTION

      2. SHORT-ACTING GROWTH HORMONES

      3. LONG-ACTING GROWTH HORMONES





  6. GLOBAL GROWTH HORMONE MARKET BY APPLICATION




  1. INTRODUCTION

  2. GROWTH HORMONE DEFICIENCY

  3. IDIOPATHIC SHORT STATURE

  4. TURNER SYNDROME

  5. SMALL FOR GESTATIONAL AGE

  6. PRADER-WILLI SYNDROME

  7. OTHERS

  8. GLOBAL GROWTH HORMONE MARKET BY REGION

    1. NORTH AMERICA

      1. US

      2. CANADA

      3. MEXICO



    2. EUROPE

      1. GERMANY

      2. FRANCE

      3. UK

      4. ITALY

      5. RUSSIA

      6. REST OF EUROPE



    3. APAC

      1. CHINA

      2. SOUTH KOREA

      3. JAPAN

      4. INDIA

      5. AUSTRALIA

      6. ASEAN

      7. REST OF APAC



    4. MIDDLE EAST & AFRICA

      1. SAUDI ARABIA

      2. UAE

      3. SOUTH AFRICA

      4. TURKEY

      5. REST OF MEA



    5. SOUTH AMERICA

      1. BRAZIL

      2. REST OF MEA

      3. ARGENTINA

      4. REST OF SOUTH AMERICA





  9. COMPETITIVE LANDSCAPE

    1. MERGERS, ACQUISITIONS, JOINT VENTURES, COLLABORATIONS,

    2. AND AGREEMENTS

      1. KEY DEVELOPMENT



    3. MARKET SHARE (%) **/RANKING ANALYSIS

    4. STRATEGIES ADOPTED BY LEADING PLAYERS



  10. COMPANY PROFILES

    • BUSINESS OVERVIEW

    • COMPANY SNAPSHOT

    • PRODUCT BENCHMARKING

    • STRATEGIC INITIATIVES

      1. ELI LILLY AND COMPANY,

      2. EMD SERONO INC.,

      3. F. HOFFMANN-LA ROCHE AG,

      4. FERRING B.V.,

      5. GENENTECH INC.,

      6. IPSEN,

      7. MERCK KGAA,

      8. NOVARTIS AG,

      9. NOVO NORDISK,

      10. PFIZER INC. AND SANDOZ,

      11. TEVA PHARMACEUTICAL INDUSTRIES.,

      12. ANHUI ANKE BIOTECHNOLOGY (GROUP) CO.,





SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

  • Single User License
    $2500
  • Site License
    $3000
  • Global License
    $5000

How can we help you?

Reach us with your research requirements and we shall provide the optimum solution to suit your needs.

Curioust about Multiple Reports?

Discounts available for multiple report purchases.

Contact Us

Our Clients

  • 3M
  • Merck
  • IBM
  • Dow
  • Henkel
  • AirBus
  • Cummins
  • Intel
  • Sony